Section Arrow
AGMB.NASDAQ
- Agomab Therapeutics NV
Quotes are at least 15-min delayed:2026/02/11 14:06 EST
Regular Hours
Last
 15.91
+0.36 (+2.32%)
Day High 
16.055 
Prev. Close
15.55 
1-M High
16.0534 
Volume 
89.78K 
Bid
15.65
Ask
16.2
Day Low
14.53 
Open
14.53 
1-M Low
12.66 
Market Cap 
757.86M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA -- 
20-SMA -- 
50-SMA -- 
52-W High 16.0534 
52-W Low 12.66 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.17/--
Enterprise Value
759.13M
Balance Sheet
Book Value Per Share
3.56
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
QNCXQuince Therapeutics0.7407+0.213+40.36%-- 
ELABPMGC Holdings Inc.1.6665-0.0435-2.54%0.01PE
RXRXRecursion Pharmaceuticals3.7-0.15-3.90%-- 
PHIOPhio Pharmaceuticals Corp1.3+0.18+16.07%-- 
LIMNLiminatus Pharma Inc0.61-0.65-51.59%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities with the aim of increasing efficacy while avoiding systemic toxicities in order to overcome the limitations of prior therapeuticapproaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.